Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of low-dose aspirin for the primary
prevention of vascular events in patients with type 2 diabetes in Japan.